ArticleFrontiers in pharmacology2025

Venetoclax concentration affects the incidence of haematological adverse events in patients with acute myeloid leukaemia.

Jing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.